Trial · NCT04456296
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Headache | Nervous system disorders | AVEED® (Testosterone Undecanoate Injection) | 1 | 222 | |
| other | Headache | Nervous system disorders | FORTESTA® (Testosterone Gel) | 2 | 223 | |
| other | Headache | Nervous system disorders | TESTIM® (Testosterone Gel) | 3 | 225 | |
| other | Blood testosterone increased | Investigations | AVEED® (Testosterone Undecanoate Injection) | 0 | 222 | |
| other | Blood testosterone increased | Investigations | FORTESTA® (Testosterone Gel) | 2 | 223 | |
| other | Blood testosterone increased | Investigations | TESTIM® (Testosterone Gel) | 3 | 225 | |
| other | Hypertension | Vascular disorders | AVEED® (Testosterone Undecanoate Injection) | 7 | 222 | |
| other | Hypertension | Vascular disorders | FORTESTA® (Testosterone Gel) | 5 | 223 | |
| other | Hypertension | Vascular disorders | TESTIM® (Testosterone Gel) | 7 | 225 | |
| serious | Acute coronary syndrome | Cardiac disorders | AVEED® (Testosterone Undecanoate Injection) | 0 | 222 | |
| serious | Acute coronary syndrome | Cardiac disorders | FORTESTA® (Testosterone Gel) | 0 | 223 | |
| serious | Acute coronary syndrome | Cardiac disorders | TESTIM® (Testosterone Gel) | 1 | 225 | |
| serious | Acute myocardial infarction | Cardiac disorders | AVEED® (Testosterone Undecanoate Injection) | 0 | 222 | |
| serious | Acute myocardial infarction | Cardiac disorders | FORTESTA® (Testosterone Gel) | 1 | 223 | |
| serious | Acute myocardial infarction | Cardiac disorders | TESTIM® (Testosterone Gel) | 0 | 225 | |
| serious | Myocardial infarction | Cardiac disorders | AVEED® (Testosterone Undecanoate Injection) | 1 | 222 | |
| serious | Myocardial infarction | Cardiac disorders | FORTESTA® (Testosterone Gel) | 0 | 223 | |
| serious | Myocardial infarction | Cardiac disorders | TESTIM® (Testosterone Gel) | 0 | 225 | |
| serious | Sepsis | Infections and infestations | AVEED® (Testosterone Undecanoate Injection) | 0 | 222 | |
| serious | Sepsis | Infections and infestations | FORTESTA® (Testosterone Gel) | 0 | 223 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04456296/events